Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytosine arabinoside as a single agent for the induction of remission in canine lymphoma.
Ruslander D, Moore AS, Gliatto JM, L'Heureux D, Cotter SM. Ruslander D, et al. Among authors: moore as. J Vet Intern Med. 1994 Jul-Aug;8(4):299-301. doi: 10.1111/j.1939-1676.1994.tb03237.x. J Vet Intern Med. 1994. PMID: 7983628
Cytosine arabinoside (AraC) was administered as a continuous IV infusion to 15 dogs with malignant lymphoma at a dose of 300 mg/m2/d for 2 consecutive days. ...
Cytosine arabinoside (AraC) was administered as a continuous IV infusion to 15 dogs with malignant lymphoma at a dose of 300 mg/m2/d …
Chemotherapy for intrathoracic cancer in dogs and cats.
Moore AS. Moore AS. Probl Vet Med. 1992 Jun;4(2):351-64. Probl Vet Med. 1992. PMID: 1643319 Review.
Although reports describing anticancer chemotherapy use in dogs and cats for tumors of the thoracic cavity largely have been anecdotal, as advances are made in the chemotherapeutic management of comparable tumors in human cancer patients and as veterinarians become …
Although reports describing anticancer chemotherapy use in dogs and cats for tumors of the thoracic cavity largely have been anecdotal, a
Intracavitary cisplatin chemotherapy experience with six dogs.
Moore AS, Kirk C, Cardona A. Moore AS, et al. J Vet Intern Med. 1991 Jul-Aug;5(4):227-31. doi: 10.1111/j.1939-1676.1991.tb00953.x. J Vet Intern Med. 1991. PMID: 1658318
Localized thermo-cisplatin therapy: a pilot study in spontaneous canine and feline tumours.
Théon AP, Madewell BR, Moore AS, Stephens C, Krag DN. Théon AP, et al. Among authors: moore as. Int J Hyperthermia. 1991 Nov-Dec;7(6):881-92. doi: 10.3109/02656739109056456. Int J Hyperthermia. 1991. PMID: 1806642
Preclinical study of sequential tumor necrosis factor and interleukin 2 in the treatment of spontaneous canine neoplasms.
Moore AS, Theilen GH, Newell AD, Madewell BR, Rudolf AR. Moore AS, et al. Cancer Res. 1991 Jan 1;51(1):233-8. Cancer Res. 1991. PMID: 1899040
Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors.
Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Curtis CR, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Ogilvie GK, et al. Among authors: moore as. J Am Vet Med Assoc. 1991 May 1;198(9):1613-7. J Am Vet Med Assoc. 1991. PMID: 2061176
The number of dogs in each evaluation period were as follows: 1 dose (n = 129), 2 doses (n = 82), 3 doses (n = 43), 4 doses (n = 26), 5 doses (n = 19), 6 doses (n = 9), 7 doses (n = 6), 8 doses (n = 5), 9 doses (n = 3), and 10 doses (n = 1). ...
The number of dogs in each evaluation period were as follows: 1 dose (n = 129), 2 doses (n = 82), 3 doses (n = 43), 4 doses (n = 26), …
Efficacy of mitoxantrone against various neoplasms in dogs.
Ogilvie GK, Obradovich JE, Elmslie RE, Vail DM, Moore AS, Straw RC, Dickinson K, Cooper MF, Withrow SJ. Ogilvie GK, et al. Among authors: moore as. J Am Vet Med Assoc. 1991 May 1;198(9):1618-21. J Am Vet Med Assoc. 1991. PMID: 2061177
Each dog was treated with mitoxantrone until the dog developed progressive disease or until the dog's quality of life diminished to an unacceptable level as determined by the owner or attending veterinarian. ...
Each dog was treated with mitoxantrone until the dog developed progressive disease or until the dog's quality of life diminished to an unacc …
Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra. A retrospective study of 15 dogs.
Moore AS, Cardona A, Shapiro W, Madewell BR. Moore AS, et al. J Vet Intern Med. 1990 May-Jun;4(3):148-52. doi: 10.1111/j.1939-1676.1990.tb00888.x. J Vet Intern Med. 1990. PMID: 2366224
Osteogenic sarcoma and myasthenia gravis in a dog.
Moore AS, Madewell BR, Cardinet GH 3rd, Shelton GD. Moore AS, et al. J Am Vet Med Assoc. 1990 Jul 15;197(2):226-7. J Am Vet Med Assoc. 1990. PMID: 2384323
Immunohistochemical evaluation of intermediate filament expression in canine and feline neoplasms.
Moore AS, Madewell BR, Lund JK. Moore AS, et al. Am J Vet Res. 1989 Jan;50(1):88-92. Am J Vet Res. 1989. PMID: 2465712
203 results
Jump to page
Feedback